Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
29.39
-1.17 (-3.83%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
↗
November 05, 2025
Via
MarketBeat
HIMS CEO Says 'A Little Bit of Craziness' Is The Secret To Building A Global Health Platform
↗
November 04, 2025
Hims & Hers Health (HIMS) CEO Andrew Dudum, sees potential for emotional and medical transformation and plans for global expansion.
Via
Benzinga
HIMS Q3 Deep Dive: Personalized Offerings and Strategic Expansion Shape Telehealth Growth
November 04, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...
Via
StockStory
Hims & Hers Health Stock Jumps After-Hours As Q3 Growth, Novo Nordisk Talks Fuel Bullish Retail Bets
↗
November 03, 2025
Revenue rose 49% year-over-year to nearly $600 million, while net income reached $15.8 million and adjusted EBITDA climbed 53% to $78.4 million.
Via
Stocktwits
Topics
Earnings
Hims & Hers Q3 Preview: GLP-1 Drug Expansion Draws Investor Focus
↗
November 03, 2025
Via
Stocktwits
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today
↗
November 03, 2025
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
Via
Benzinga
Hims Hers (HIMS) Q3 2025 Earnings Call Transcript
↗
November 03, 2025
Hims Hers (HIMS) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks
November 03, 2025
Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Hims Says It's Negotiating A New Deal With Novo Nordisk; Shares Surge
↗
November 03, 2025
Hims & Hers Health said late Monday it's in discussions with Novo Nordisk to sell Wegovy shots. The news buoyed Hims stock.
Via
Investor's Business Daily
Hims & Hers Stock Pops After Q3 Earnings: Here's Why
↗
November 03, 2025
Here's a look at the Q3 earnings report from Hims & Hers Health.
Via
Benzinga
Hims & Hers Health’s (NYSE:HIMS) Q3 Sales Top Estimates
November 03, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 49.2% year on year to $599 million. On the other hand, next...
Via
StockStory
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
November 03, 2025
From
Hims & Hers
Via
Business Wire
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
↗
November 03, 2025
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
Via
Benzinga
Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains— Micron Tech, Palantir, Hims & Hers In Focus
↗
November 03, 2025
U.S. stock futures advanced on Monday after Friday’s positive moves. Futures of major benchmark indices were higher.
Via
Benzinga
Topics
Stocks
Hims & Hers Health (HIMS) Q3 Earnings: What To Expect
November 01, 2025
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings this Monday afternoon. Here’s what you need to know.
Via
StockStory
Why Hims & Hers Health (HIMS) Stock Is Trading Up Today
October 31, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.4% in the afternoon session after JPMorgan Chase & Co. disclosed in a regulatory filing that it had taken a significant passive...
Via
StockStory
10 Health Care Stocks Whale Activity In Today's Session
↗
October 30, 2025
Via
Benzinga
1 Profitable Stock on Our Watchlist and 2 We Find Risky
October 29, 2025
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...
Via
StockStory
Topics
Retirement
Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
↗
October 24, 2025
Hims & Hers stock is falling well off its 52-week highs, as bears lean on the CEO's scheduled sale that just took place, though it might be a mistake.
Via
MarketBeat
1 Mid-Cap Stock Worth Your Attention and 2 We Avoid
October 23, 2025
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...
Via
StockStory
Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
↗
October 22, 2025
Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat.
Via
Benzinga
Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
October 21, 2025
The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic...
Via
MarketMinute
Topics
Economy
Stocks
World Trade
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
October 21, 2025
Via
Benzinga
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
October 20, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.9% in the morning session after investors looked past a recent insider stock sale and focused on the company's strong growth...
Via
StockStory
Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks
↗
October 18, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via
Benzinga
Topics
World Trade
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
↗
October 17, 2025
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
Via
Benzinga
Topics
ETFs
Government
Why Is Hims & Hers Health Stock Down 12% Today?
↗
October 17, 2025
According to a SEC filing on Thursday, CEO Andrew Dudum sold 175,661 shares of the company for an aggregate value of about $11 million.
Via
Stocktwits
Topics
Regulatory Compliance
Why Hims & Hers Health Shares Are Sliding Friday
↗
October 17, 2025
Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease.
Via
Benzinga
Topics
Government
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
↗
October 16, 2025
Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss drugs are going to go down in price.
Via
Benzinga
Topics
Government
< Previous
1
2
3
4
5
6
7
8
9
...
53
54
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit